Bleharski Joshua
SEC insider (Form 3/4/5 filer). CIK 0002075052. Director at Scribe Therapeutics, Inc. (SCTX) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Jul 23, 2026. Located in ALAMEDA, CA.
Companies Bleharski Joshua has filed insider reports for
- Scribe Therapeutics, Inc. (SCTX): Director
- IDEAYA Biosciences, Inc. (IDYA): Officer, Chief Financial Officer
Bleharski Joshua
CIK: 0002075052
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
